The Patent Finder

Shionogi Inc.

Also on record
Records under this name other than the patents Shionogi Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Back to Shionogi Inc.

PatentTitleStatus Expires Confidence
US 11,740,219Analysis Method of 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,320,793Analysis Method of 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,778,924Modified release amoxicillin products
Lapsed on the fee record
Ended Jul 15, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 15, 2026Medium confidence
US 8,758,820Robust pellet
Lapsed on the fee record
Ended Jun 24, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 24, 2026From the USPTO record
US 8,715,727Tablet for pulsed delivery
Lapsed on the fee record
Ended May 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 6, 2026From the USPTO record
US 8,460,710Antibiotic product, use and formulation thereof
Lapsed on the fee record
Ended Jun 11, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 11, 2025From the USPTO record
US 8,425,936Antibiotic product, use and formulation thereof
Lapsed on the fee record
Ended Apr 23, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 23, 2025From the USPTO record
US 8,357,394Compositions and methods for improved efficacy of penicillin-type antibiotics
Lapsed on the fee record
Ended Jan 22, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 22, 2025From the USPTO record
US 8,313,775Antibiotic product, use and formulation thereof
Lapsed on the fee record
Ended Nov 20, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 20, 2024From the USPTO record
US 8,313,776Antibiotic product, use and formulation thereof
Lapsed on the fee record
Ended Nov 20, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 20, 2024From the USPTO record
10 of 64 patents shown.
Pro members see all 64.
Pro members: see all 64 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited